MDI Health Overview
MDI Health has developed an AI-driven pharmacology platform capable of performing multidimensional context-based analyses of thousands of pharmacological and patient-specific parameters in order to autonomously optimize personal medication regimens across the entire population. The company’s powerful artificial intelligence is used by payers and value-based providers to identify high-risk patients for adverse drug events, to make changes in order to reduce those risks in real time, and to execute the given recommendations, thereby reducing total care costs while improving quality.
Cumulative Funding Raised Over Time ($)
Latest News
growth-positive
MDI Health raises $20 million for customized AI medication platform | CTech
Israeli startup MDI Health has raised $20 million in funding led by Intel Capital. The company develops a platform that helps manage medication and customize it for each patient. MDI Healths technology automates comprehensive medication reviews (CMRs) for clinicians, allowing them to complete them in minutes instead of hours. The funding will be used to meet customer demand, expand research and development teams, and increase the companys valuation. MDI Healths mission is to prevent drug-related medical problems, which is the fourth leading cause of death in the United States.
InvestmentExpand
Neutral
https://www.bloomberg.com/press-releases/2022-03-01/healthcare-veteran-joins-mdi-health-as-coo-advancing-its-automated-pharmacology-intelligence-platform-to-optimize-medication
The article is a brief description of Bloombergs Daybreak Europe program. It is anchored live from London and provides breaking news from Europe and around the world. The program also allows investors to monitor their investments 24 hours a day, around the clock from around the globe.
Long-Time CEO of Blue Cross Blue Shield AZ, Richard Boals, Joins MDI Health
growth-positive
MDI Health announces $6 million seed round, launches personalized AI medication platform
Israeli startup MDI Health has launched its end-to-end AI platform for personalized medication. Recent clinical trials at Hadassah University Hospital in Israel showed that the AI platform presented up to 40% more life-saving patient insights than clinical pharmacists had identified. MDI Health has completed a $6 million seed round led by Hanaco Ventures, bringing its total funding to $7 million. The company aims to solve medication-related problems, which is the fourth-largest cause of world deaths. MDI Health has also announced the launch of new pilots in the U.S. with a top health insurer and health systems.
InvestmentPartners
growth-positive
https://www.jpost.com/Opinion/Hillels-Tech-Corner-MDI-Health-brings-precision-to-medical-prescriptions-610782
MDI Health is a company that uses AI algorithms and machine learning models to improve medication treatment and prevent medication-related problems. They aim to blend expert human intelligence with machine intelligence for better medication management. The company has raised a pre-seed funding round led by Jumpspeed VC and Freshfund. The impact of MDI Health is positive for both patients and clinicians, as it provides safer and more personalized medication treatment. The article discusses the challenges in medical prescriptions and the need for a paradigm shift in medication management.
Customers
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $30.5M |
| Last funding | $20M |
| Stage | A |
| Rounds | 5 |
| Investors | 8 |
Team Members
4
Employees: 51-200
Web & Social Links
| Website | www.mdihealth.com/ |
| Careers | Careers page |
Locations
Tel Aviv-Yafo, Israel
Los Angeles, CA, USA
Photos & Videos
No files yet
